Mode of recovery from the effects of heterologous anti-lymphocyte serum. II. Recovery of the cells involved in antibody production.
D000818:Animals; D000921:Antibody-Producing Cells / Q000187:drug effects*; D000961:Antilymphocyte Serum / Q000032:analysis / Q000494:pharmacology*; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D002465:Cell Movement; D003520:Cyclophosphamide / Q000494:pharmacology; D004912:Erythrocytes / Q000276:immunology; D008198:Lymph Nodes / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D051379:Mice; D012756:Sheep; D013154:Spleen / Q000166:cytology / Q000187:drug effects / Q000276:immunology / Q000637:transplantation; D013950:Thymus Gland / Q000166:cytology; D013997:Time Factors; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D003520:Cyclophosphamide